Personalized test aims to match cancer patients with best drug
NCT ID NCT07171554
Summary
This study is testing a new diagnostic tool called µCAN. It analyzes a small piece of a patient's tumor in a lab to see which cancer drugs might work best for their specific case. The goal is to give doctors better information to choose the next line of treatment for people with advanced colorectal cancer that has spread. The study will enroll 75 adults whose initial treatment has stopped working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (MCRC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Akershus University Hospital
Lørenskog, Akershus, 1478, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.